MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-10-0005414
Octofeb Pharma Private Limited
Octofeb Pharma Private Limited - pharma in Karnal, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.33 Cr
▲ 69% YoY
Net profit · FY 2025
₹1.91 Lakh
Net margin 1.4%
EBITDA · FY 2025
₹6.79 Lakh
EBITDA margin 5.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹34.25 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About Octofeb Pharma Private Limited
Data last updated:
Octofeb Pharma Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24304HR2017PTC068918. Its GSTIN is 06AACCO4953F1ZI (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anshul Kumar and Gaurav Dawar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor Plot No. 208 – B Sector 3 Hsiidc Industrial Estate, Karnal, Haryana, India – 132001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.33 Cr, a growth of 69% compared to the previous year. For the same year it recorded a net profit of ₹1.91 Lakh (net margin 1.4%) and EBITDA of ₹6.79 Lakh (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 61% over three years and 53% over five years.
As per MCA filings, the company has open charges of ₹34.25 Lakh on record.
Octofeb Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0005414). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Octofeb Pharma Private Limited
CIN U24304HR2017PTC068918
Registration Number 068918
Incorporation Date 04 May 2017
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-10-0005414
Key People
Anshul Kumar Director Gaurav Dawar Director Recognitions & Rankings of Octofeb Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGround Floor Plot No. 208 – B Sector 3 Hsiidc Industrial Estate, Karnal, Haryana, India – 132001
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Octofeb Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Octofeb Pharma Private Limited
The main business activity of Octofeb Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Octofeb Pharma Private Limited FY 2025 filings available
Octofeb Pharma Private Limited reported revenue of ₹1.33 Cr (up 69% YoY) for FY 2025.
Revenue · FY 2025
₹1.33 Cr ▲ 69%
Net profit · FY 2025
₹1.91 Lakh margin 1.4%
EBITDA · FY 2025
₹6.79 Lakh margin 5.1%
Compounded Annual Growth Rate (CAGR) of Octofeb Pharma Private Limited
Revenue CAGR growth
1 year
▲ 69%
3 years · compounded
▲ 61%
5 years · compounded
▲ 53%
EBITDA CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 43%
5 years · compounded
▲ 25%
Revenue has grown at a compounded annual rate (CAGR) of 53% over five years, including 69% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Octofeb Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.79 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.91 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Octofeb Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Octofeb Pharma are in the company report.
Premium access
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Octofeb Pharma Private Limited
Octofeb Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anshul Kumar | Director | 04 May 2017 | 9 Years 5 Months | Current |
| Gaurav Dawar Also directs: Octofeb Steel Private Limited | Director | 04 May 2017 | 9 Years 5 Months | Current |
Peer Comparison of Octofeb Pharma Private Limited
Octofeb Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aizher Fine Chem Private Limited | ₹1.33 Cr (FY 2025) | •••• | •••• | 52.0% | •••• | Thane, Maharashtra, India |
| Allen Homoeo International Private Limited | ₹1.33 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Kolkata, West Bengal, India |
| Eco Health Products Private Limited | ₹1.33 Cr (FY 2024) | •••• | •••• | -35.0% | •••• | Chennai, Tamil Nadu, India |
| Berkshire. Med Private Limited | ₹1.33 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Jalandhar, Punjab, India |
| Medline Pharmaceuticals Private Limited | ₹1.33 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Bharaniputtur, Chennai-101, Tamil Nadu, India |
| Octofeb Pharma Private Limited this company | ₹1.33 Cr (FY 2025) | •••• | •••• | 69.0% | •••• | Karnal, Haryana, India |
| Zuari Envien Bioenergy Private Limited | ₹1.33 Cr (FY 2025) | •••• | •••• | 205.0% | •••• | Gurugram, Haryana, India |
| Veera Crop Care Private Limited | ₹1.33 Cr (FY 2024) | •••• | •••• | •••• | Ghaziabad, Uttar Pradesh, India | |
| Oxygenx Industries Private Limited | ₹1.33 Cr (FY 2025) | •••• | •••• | -32.0% | •••• | Kolkata, West Bengal, India |
| Link Lab Pvt Ltd | ₹1.33 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | Hyderabad, Telangana, India |
| Eksoy Chemicals India Private Limited | ₹1.33 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Octofeb Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Octofeb Pharma Private Limited
Octofeb Pharma Private Limited is audited by KUMAR AVNEET & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KUMAR AVNEET & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Octofeb Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Octofeb Pharma Private Limited
Open charges
₹34.25 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Nov 2021 | Canara Bank | ₹4.25 Lakh | Open |
| 17 Dec 2019 | Canara Bank | ₹30 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Octofeb Pharma Private Limited
Employment history and EPFO contributions of people linked to Octofeb Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Octofeb Pharma Private Limited
Octofeb Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Anshul Kumar was appointed as Director on 04 May 2017.
AGM
Octofeb Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Octofeb Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Charges
A charge with Canara Bank of Rs. 30.00 Lakh registered on 17 Dec 2019 with Charge ID 100316836 was modified on 22 Jan 2025.
Charges
A charge with Canara Bank amounted to Rs. 4.25 Lakh with Charge ID 100509006 was registered on 18 Nov 2021.
Charges
A charge with Canara Bank amounted to Rs. 30.00 Lakh with Charge ID 100316836 was registered on 17 Dec 2019.
Appointed
Anshul Kumar was appointed as Director.
Appointed
Gaurav Dawar was appointed as Director.
Incorporation
04 May 2017
Octofeb Pharma Private Limited was registered on 04 May 2017 with Roc Haryana & aged 9 years 5 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Octofeb Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Octofeb Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Octofeb Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Octofeb Pharma Private Limited
Octofeb Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCO4953F1ZI | Haryana | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Octofeb Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Octofeb Pharma Private Limited
Octofeb Pharma is an active private limited company based in Karnal, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 May 2017 (9+ years old) and is registered under CIN U24304HR2017PTC068918.
Octofeb Pharma reported revenue of ₹1.33 Cr for FY 2025 (up 69% YoY).
Octofeb Pharma has 2 current directors:
- Anshul Kumar - Director
- Gaurav Dawar - Director
Octofeb Pharma reported a net profit of ₹1.91 Lakh (net margin 1.4%) and EBITDA of ₹6.79 Lakh (EBITDA margin 5.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Octofeb Pharma is 61% over three years and 53% over five years. In the latest year (FY 2025) revenue rose 69%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Octofeb Pharma is 06AACCO4953F1ZI, registered in Haryana.
The CIN (Corporate Identification Number) of Octofeb Pharma is U24304HR2017PTC068918. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Octofeb Pharma was incorporated on 04 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Octofeb Pharma by revenue are Aizher Fine Chem Private Limited, Allen Homoeo International Private Limited, Eco Health Products Private Limited, Berkshire. Med Private Limited, Medline Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anshul Kumar was appointed as Director on 04 May 2017. Gaurav Dawar was appointed as Director on 04 May 2017.
Yes, Octofeb Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-10-0005414).